Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Lanny Sun
AddedMar 31, 2024
UpdatedMay 31, 2026
Lanny Sun

Lanny Sun

Co-Founder, Roivant Sciences

CrunchbaseLinkedIn

Lanny Sun's Career

Roivant Sciences
Roivant Sciences

New York City, NY, US

Co-Founder
TandemAI
TandemAI

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Lanny Sun's Career

Roivant Sciences
Roivant Sciences
Public$2.5B2672014New York City, NY, US
Co-Founder

Leadership at Roivant Sciences

Atul PandeAtul PandeBoard Member
Andrew LoAndrew LoBoard Member
Ilan Ben OrenIlan Ben OrenBoard Member
Jim MomtazeeJim MomtazeeBoard Member
Matthew GlineMatthew GlineCEO
George MigauskyGeorge MigauskyBoard Member
TandemAI
TandemAI
Series A$60M462021New York City, NY, US
Board Member· Board

Leadership at TandemAI

Tom TangTom TangCo-Founder
Jeff HeJeff HeCo-Founder

Similar to TandemAI

Zephyr AIZephyr AIDallas, TX, USDrug Discovery, Precision Medicineest. 2020Zephyr AIDallas, TX, US · est. 2020

Zephyr AI: Revolutionizing healthcare with innovative drug discovery and precision medicine tech.

Seed · $18.5M47
DeepCureDeepCureBoston, MA, USDrug Discoveryest. 2018DeepCureBoston, MA, US · est. 2018

DeepCure: Accelerating affordable AI-powered drug discovery for better, faster results.

Series A · $40M39
Phronesis Artificial IntelligencePhronesis Artificial IntelligenceDaphne, AL, USPharmaceutical Softwareest. 2020Phronesis Artificial IntelligenceDaphne, AL, US · est. 2020

Phronesis AI develops advanced pharmaceutical software for autonomous drug discovery and disease targeting.

Angel · $300k7
Terray TherapeuticsTerray TherapeuticsPasadena, CA, USDrug Discoveryest. 2018Terray TherapeuticsPasadena, CA, US · est. 2018

Terray, an AI-driven company, optimizes drug discovery to transformative therapeutics.

Series D · $80M95

Lanny Sun's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Lanny Sun

Joel BraunsteinJoel BraunsteinFounder · Tivorsan PharmaceuticalsRichard ChinRichard ChinFounder · Vetmab BiosciencesSawan HurstSawan HurstCo-Founder · Phi Life SciencesEric HowieEric HowieCo-Founder · Life Detection TechnologiesJeremy AllaireJeremy AllaireBoard Member · Ping IdentityRandall LanhamRandall LanhamCo-Founder · Road Runner Media